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ABSTRACT  
Mutraghata is a group of Obstructive Uropathy disorders which has been 
dealt in detail in almost all ancient treatises, in which the Mutragranthi, 
Mutrasanga, Bastikundalika & Mutrastheela are the conditions which are 
similar to the BPH in respective of obstructive as well as irritative phases. 
Benign prostatic hyperplasia (BPH) is a common cause of male lower 
urinary tract symptoms (LUTS). BPH is a senile disorder and chiefly 
affects individuals above the age of 40 years. The symptoms are 
increased frequency of micturition, dribbling, hesitancy, and the features 
of chronic urinary retention. The symptoms of benign prostatic 
hyperplasia (BPH) closely resemble both in anatomically and 
symptomatically with Vatastheela which is mentioned in Ayurvedic text. 
Surgical management has been accepted as the standard management 
but is associated with many disadvantages as well as complications, 
which may not be acceptable at this age. Conservative management with 
modern medicines is also not free from side effects. So, in this age-group, 
there is a need for much safer alternative method of management. 
Mustadi kalpa cited by Acharya Sushruta in the context of Mutraghat 
chikitsa is a well known therapeutic drug in this context. A study was 
carried out to evaluate its efficacy in which 30 patients were selected for 
the trail with the symptoms of BPH and were subjected to administration 
of Mustadi kalpa in the dose of 10 mg TDS in divided doses orally for 45 
days. The Total effect of the formulation has provided considerably 
significant relief on the subjective as well as objective parameters. 
Mustadi kalpa was found safe and effective in symptomatic management 
of Mootraghata (BPH) by virtue of its Shothhara, Balya, Tridoshhara and 
Vatanuloman properties. 
 
INTRODUCTION 
 Despite intense research efforts in the last 
three decades to elucidate the underlying etiology 
of prostate growth in older men, the cause and 
effect relationship have not been established. The 
symptoms associated with BPH are common and 
their frequency increases with the age. The 
incidence of BPH can be as high as 50% by the age 
60 and 90% by the age 85 years. It is estimated that 
in men 80 years or more 90% show histological 
evidence of the condition, 81% have BPH related 
symptoms and 10% suffer from urinary retention[1]. 
Surgical management has been accepted as the 
standard management but is associated with many 
disadvantages as well as complications, which may 
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not be acceptable at this age. Conservative 
management with modern medicines is also not 
free from side effects namely retrograde 
ejaculation, hypotension, impotency, nasal 
blockage, skin rashes, etc. In order to avoid these 
side effects of conservative treatment, patients opt 
for surgery but considering their age & other 
diseases they usually end up with post-operative 
complications such as hemorrhage, stricture, sepsis, 
incontinence, bladder neck contracture, etc. & it is 
now known that after eight years 15-18% of men 
with BPH will undergo repeated TURP & rate after 
open prostatectomy is about 5% [2-3]. So, in this age-
group, there is a need for much safer alternative 
method of management. In this regard, many works 
have been carried out and shown that the 
Ayurvedic approach, using natural medicines, is a 
far better approach. In Ayurveda, Mutraghata 
(Obstructive uropathy) is described in detailed with 
their management in our classics, especially in 
Sushruta Samhita[4,5,6]. The symptoms of benign 
prostatic hyperplasia (BPH) closely resemble both 
in anatomically and symptomatically with 
Vatastheela which is mentioned in Ayurvedic text. 
The vitiated Vata gets lodged between the bladder 
and rectum and produces the stony hard swelling. 
The various symptoms are Chala unnata granthih 
(singly movable and elevated) Vinmutranila sanga 
(retention of urine, faeces and flatus) Basti 
adhmana (distension of the urinary bladder) and 
Vedana (excruciating pain in the bladder)[7]. 
Mustadi kalpa cited by Acharya Sushruta in the 
context of Mutraghat chikitsa has Deepan, Pachan, 
Shothhar, Kaphavatahara, Lekhana, Vatashodhaka 
and Mootrala actions and is said to be effective in 
Mootramarg avrodha [8,10].  
MATERIAL AND METHODS 
 The patients were randomly selected from 
the O.P.D. & I.P.D. of Jammu Institute of Ayurveda 
and Research and diagnosed on the basis of both 
the Subjective and Objective criteria of Vatastheela - 
BPH irrespective of their age, religion, race, 
occupation etc. Some patients with greater degree 
of Bladder outlet obstruction, acute retention of 
urine requiring catheterization and those with 
impeding upper urinary tract affections were 
excluded from study.  
AIMS AND OBJECTIVES 
 To study the effects of Mustadi kalpa in the 
management of Vatastheela, with special reference 
to BPH. 
 Inclusion Criteria  
 Age group between 40 – 70 years. 
 Signs and symptoms of Vatastheela /BPH. 
Exclusion Criteria 
 Patients below 40 and above 70 years of age 
 Acute retention of urine. 
 Prostatic carcinoma 
 Prostatitis 
 Neurogenic bladder 
 Urethral stricture 
 urinary calculi 
 renal failure 
Plan of Work 
1.  A thorough history, General examinations, and 
Systemic examinations were conducted and 
duly recorded in the special proforma prepared 
for the study on the basis of IPSS score.  
2.  Investigations 
 Digital and ultrasonographic examination of 
the prostate gland. 
 Residual urine volume assessment by 
ultrasonography. 
 Urine flow rate measurement. 
 Routine hematological examination.  
 PSA, if necessary. 
 3.  The selected patients were subjected to 
administration of Mustadi kalpa in the dose of 
10 mg TDS in divided doses orally for 45 days. 
The Pathya regimen was advised to be followed 
throughout the entire schedule. 
 (b) Mustadi kalpa in the dose of 10 mg TDS in 
divided doses orally for 45 days. 
International Prostate Symptom Score (IPSS) 
  Not 
at all 
Less than 
1 time in 
5 
Less than 
half the 
time 
About 
half the 
time 
More than 
half the 
time 
Almost 
always 
Incomplete emptying 
Over the past month, how often have 
you had a sensation of not emptying 
your bladder completely after you 
finish urinating? 
0 1 2 3 4 5 
Frequency 0 1 2 3 4 5 
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Over the past month, how often have 
you had to urinate again less than two 
hours after you finished urinating? 
Intermittency 
Over the past month, how often have 
you found you stopped and started 
again several times when you 
urinated? 
0 1 2 3 4 5 
Urgency 
Over the last month, how difficult 
have you found it to postpone 
urination? 
0 1 2 3 4 5 
Weak stream 
Over the past month, how often have 
you had a weak urinary stream? 
0 1 2 3 4 5 
Straining  
Over the past month, how often have 
you had to push or strain to begin 
urination? 
0 1 2 3 4 5 
Nocturia 
Over the past month, many times did 
you most typically get up to urinate 
from the time you went to bed until 
the time you got up in the morning? 
0 1 2 3 4 5 
DRUG CONTRIVE 
Mustadi Kalpa Ingredients 
1. Musta 
2. Abhaya 
3. Devadaru 
4. Moorva 
5. Yashtimadhu 
Method of preparation: Each of the ingredients 
were taken and cleaned then powdered separately 
and then they were mixed thoroughly and were 
sieved through a cloth to acquire Vastra galitha 
churna. 
Packing: 100 gm of Vastra galitha churna of 
Mustadi kalpa was packed in a moist free plastic 
container. 
Amayika prayoga: Mutraghata, Mutrastheela, 
Ashmari, Mutrakrucchra etc. 
Dose: 10 gms TDS in divided doses. 
Anupana: Ushna jala. 
The above formulation is mainly having Deepana, 
Pachana, Mutrala, Vatanulomana, Shothahara, 
action and it is supplemented by Rasayana, Balya 
effect and that is what needed in the management 
of the disease Mutraghata [8]. 
Pathya-Apathya 
 Vegetables are associated with decreased 
risks of BPH and lower urinary tract symptoms. 
Patients suffering from urinary disorders Takra, 
Cow’s milk, Guava, drumstick pods, Pancha Jeeraka, 
Shali rice, Draksha, coconut water, barley water, 
Jaggery (i.e., Purana guda), Khanda (i.e., brown 
sugar), sugarcane juice, Coriander etc are beneficial. 
Apart from these, substances or drinks which have 
diuretic property will be helpful in the management 
of urinary disorders.  
 Guru (i.e., difficult to digest), Vidahi (i.e., 
produces burning in the GIT) and Abhisyandi (i.e., 
obstructing fine channels) substances like curd, 
peas, cauliflower, brinjal, dry mango powder and 
over exercise etc are not suitable for patients 
suffering with urinary diseases [9]. 
OBSERVATIONS AND RESULTS: 
Table 1: Age in years 
S.No. Age No. of Patients Percentage 
1 40-50 3 10.00% 
2 51-60 20 66.66% 
3 61-70 7 23.33% 
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Table 2: Addiction 
Addiction No. of Patients Percentage 
Smoker 8 26.67% 
Tobacco 6 20.00% 
Alcoholic 13 43.33% 
None 3 10.00% 
Table 3: Bowel Habit 
Bowel habit No. of Patients Percentage 
Regular 8 26.67% 
Constipated 22 73.33% 
Table 4: Prakriti 
Prakriti No. of Patients Percentage 
Vata – pittaja 18 60.00% 
Vata – kaphaja 8 26.67% 
Pitta – kaphaja 4 13.33% 
Table 5: Treatment efficacy 
Variable Mean SD SE t- value p - value Remark 
BT AT 
Incomplete 
voiding 
3.15 0.20 0.80 0.17 16.39 <0.001 HS 
Frequency 3.05 0.45 0.73 0.16 15.82 <0.001 HS 
Intermittency 0.55 0.10 0.58 0.13 3.41 <0.001 HS 
Urgency 2.85 1.30 1.05 0.23 5.51 <0.001 HS 
Weak stream 3.15 0.25 0.94 0.21 13.74 <0.00I HS 
Strangury 0.65 0.30 0.47 0.10 3.28 <0.00I HS 
Nocturia 3.00 0.75 0.82 0.18 12.13 <0.001 HS 
Table 6: Urine Flow Rate 
Urine flow rate (ml/sec.) No of patiens Percentage 
BT AT BT AT 
>15 8 14 26.67% 46.66% 
10-15 21 16 70% 53.33% 
<10 1 0 3.33% 0.00% 
Table 7: Residual Urine 
Residual urine No of patients Percentage 
BT AT BT AT 
50-100 11 18 36.67% 36.66% 
101-150 9 9 30.00% 30.00% 
151-200 10 3 33.33% 33.33% 
DISCUSSION 
 Age wise distribution of patients shows that 
most of them were from the age group of 51–46 
years and addiction wise distribution shows most of 
the patients were alcoholic (43.33%) and with 
constipated bowel habits (73.33%). Majority of the 
patients were having Vata-pittaj (60.00%) and 
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Vata-kaphaj (26.67%) Prakriti. Based upon the 
above observations, the effect of therapy on all the 
parameters if IPSS score i.e. incomplete voiding, 
frequency, nocturia, urgency, weak stream, 
strangury and intermittency in the patients of 
Vatastheela is found significant as the ‘p’ value in all 
the parameters is less than 0.05. In Vatastheela, the 
vitiated Apana vayu when takes shelter in the space 
between Basti and Shakrut marga (i.e. Guda) 
produces Ghana, Achala, Unnata astheelavatha 
granthi. The growth in turn produces obstruction to 
the passage of Vitta, Mutra, Anila and leads to 
Aadhmana of the Basti and also pain in the region of 
Basti. In Mustadi kalpa most of the drugs have 
Kashaya and Tikta rasa, Ushna veerya, Madhura 
vipaka and Kapha vata shaamaka and this 
improvement can be understood on the basis of 
Shothhara, Balya, Tridoshhara and Vatanuloman 
properties of the drug, resulting into decrease in the 
symptoms and allowing free and comparatively 
more passage of urine than earlier. Although the 
size of prostate was not decreased after the 
treatment, but there is relatively increase in urine 
flow rate and decrease in residual urine. 
CONCLUSION 
 Benign prostatic hyperplasia is a very 
common disorder in elderly male persons. It affects 
the quality of life and physiology of urination. 
Prolonged BPH may result in bladder calculi, 
haematuria and retention of urine may leads to 
hydro-ureter, hydronephrosis and lastly renal 
insufficiency. Ayurveda has plenty of drugs quite 
helpful by acting on Mootravaha srotas (renal 
system) that are diuretic, anti-inflammatory, 
analgesic and antiseptic in nature. Ayurvedic 
medication, suitable dietary pattern and lifestyle 
modification contributes in the prevention of BPH. 
This study highlighted that Mustadi kalpa is safe 
and effective in symptomatic management of 
Mootraghata (BPH) by virtue of its Shothhara, 
Balya, Tridoshhara and Vatanuloman properties. As 
this is a pilot study, it should be tried in more 
number of patients for its validation. 
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